30 Day Trial

Medicrea Gains FDA Clearance for Patient-Matched Interbody Cages


Medicrea gained FDA 510(k) clearance for UNiD® IB3D Patient-Matched interbody cages, completing its UNiD® ASI (Adaptive Spine Intelligence) platform.

The 3D-printed titanium implants allow customization of cage dimensions, features and endplate morphology, reportedly representing the first time that this level of customization is commercially available in spinal devices.

The cages are specifically designed to match the patient’s surgical and anatomical requirements, determined by UNiD LAB engineers during the pre-op planning. UNiD IB3D Patient-Matched interbody cages allow the surgeon to accommodate geometrical inconsistencies (such as an asymmetric anatomy) of endplates and vertebral bodies, thus improving surgical and clinical outcomes.

Medicrea just marked the milestone of more than 5,000 procedures using the UNiD ASI platform and patient-specific implants.